Affiliation: Wingate University
- Recent advances in the secondary prevention of coronary heart diseaseAngie Veverka
Wingate University School of Pharmacy, Campus Box 3087, Wingate, NC 28174 0157, USA
Expert Rev Cardiovasc Ther 2:877-89. 2004....
- Nebivolol: a third-generation beta-adrenergic blockerAngie Veverka
School of Pharmacy, Wingate University, NC 28174, USA
Ann Pharmacother 40:1353-60. 2006..To describe the pharmacologic and pharmacokinetic properties of a new beta-adrenergic blocker, nebivolol, and review the literature evaluating its efficacy in the treatment of hypertension and heart failure...
- Nebivolol in the treatment of chronic heart failureAngie Veverka
Wingate University School of Pharmacy, 316 North Main Street, Wingate, NC 28174 0157, USA
Vasc Health Risk Manag 3:647-54. 2007..This article will review the pharmacologic and pharmacokinetic properties of nebivolol as well as clinical studies assessing its efficacy for the treatment of heart failure...
- Cardiovascular medication prescribing in older adults with psychiatric disordersChristian R Dolder
Wingate University School of Pharmacy, Wingate, NC 28174, USA
Consult Pharm 22:660-8. 2007..Secondary aims included examining: 1) if differences in CV medication prescribing existed between admission and discharge and 2) if differences in CV medication prescribing existed between patients with and without dementia...
- Urate-lowering therapy for gout: focus on febuxostatBryan L Love
Wingate University School of Pharmacy, Wingate, North Carolina 28174, USA
Pharmacotherapy 30:594-608. 2010....
- Risk of cancer associated with the use of angiotensin II-receptor blockersJacqueline L Olin
School of Pharmacy, Wingate University, 515 North Main Street, Wingate, NC 28174, USA
Am J Health Syst Pharm 68:2139-46. 2011....